Please turn JavaScript on
Find more feeds

Aplastic Anemia and MDS International Foundation (AAMDSIF)

Want to know the latest news and articles posted on Aplastic Anemia and MDS International Foundation (AAMDSIF)?

Then subscribe to their feed now! You can receive their updates by email, via mobile or on your personal news page on this website.

See what they recently published below.

Website title: The Aplastic Anemia & MDS International Foundation | Aplastic Anemia and MDS International Foundation (AAMDSIF)

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.75 / day

Message History

Xiaoyi Chen, MD, PhD
Xiaoyi Chen, MD, PhD Ayanna Hawkins Fri, 08/21/2026 - 08:46 Position / Title Assistant Professor Institution Rutgers Cancer Institute of New Jersey Online Profile https://cinj.org/xiaoyi-chen-md-phd Primary Disease Area of Focus Acute Myeloid Leukemi...

Read full story
Mapping Human Bone Marrow Yields New Tool, Insights on Blood Cancer
Mapping Human Bone Marrow Yields New Tool, Insights on Blood Cancer Tricia Maddrey Baker Wed, 08/19/2026 - 13:16

Read full story
Treatment modalities and the impact of granulocyte colony-stimulating factor in AML patients treated with venetoclax...
Treatment modalities and the impact of granulocyte colony-stimulating factor in AML patients treated with venetoclax and azacitidine: A DATAML registry study Tricia Maddrey Baker Wed, 08/19/2026 - 13:13

Read full story
Eltrombopag Added to Standard Immunosuppressive Treatment as Front-Line Therapy for Severe Aplastic Anemia: Long-Ter...
Eltrombopag Added to Standard Immunosuppressive Treatment as Front-Line Therapy for Severe Aplastic Anemia: Long-Term Outcomes of the Phase-3 Randomized Superiority EBMT-SAAWP RACE Study  Tricia Maddrey Baker Wed, 08/19/2026 - 13:11

Read full story
Venetoclax-enhanced reduced-intensity conditioning in older patients aged ≥55 years with high-risk myeloid malignanc...
Venetoclax-enhanced reduced-intensity conditioning in older patients aged ≥55 years with high-risk myeloid malignancies undergoing allogeneic peripheral blood stem cell transplantation: A phase II study Tricia Maddrey Baker Wed, 08/19/2026 - 13:09

Read full story